Acute hemolytic transfusion reaction
Acute Hemolytic Transfusion Reaction (AHTR) is a severe complication that can occur during a blood transfusion. It is characterized by the rapid destruction of red blood cells (RBCs) that can lead to serious health problems such as kidney failure and shock.
Causes[edit]
AHTR is most commonly caused by the transfusion of ABO incompatible blood, which means the donor's blood type does not match the recipient's. This can occur due to errors in blood typing or crossmatching procedures. Other causes include the transfusion of blood that has been contaminated with bacteria or that is incompatible in other blood group systems.
Symptoms[edit]
The symptoms of AHTR can vary widely, but often include fever, chills, chest or back pain, nausea, and dark urine. In severe cases, patients may experience hypotension, tachycardia, disseminated intravascular coagulation (DIC), and acute kidney injury.
Diagnosis[edit]
Diagnosis of AHTR is based on clinical symptoms and laboratory findings. Laboratory tests may show an increase in bilirubin levels, a decrease in haptoglobin levels, and the presence of free hemoglobin in the urine. A direct antiglobulin test (DAT) may also be positive.
Treatment[edit]
Treatment of AHTR involves stopping the transfusion immediately and providing supportive care. This may include intravenous fluids, oxygen, and medications to control symptoms. In severe cases, dialysis may be required.
Prevention[edit]
Prevention of AHTR involves careful blood typing and crossmatching procedures to ensure that the donor's blood is compatible with the recipient's. In addition, blood products should be properly stored and handled to prevent bacterial contamination.
See also[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian